Previous studies have focused on C-reactive protein (CRP) or cytokines as markers of inflammation [5, 6] but alternative biomarkers are needed to further improve detection of a subclinical inflammatory state and facilitate risk prediction in individuals with CKD. Here, CRP is linked to chronic kidney disease.